These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33268518)

  • 1. Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza A Virus Infection to Unvaccinated Pigs.
    Everett HE; van Diemen PM; Aramouni M; Ramsay A; Coward VJ; Pavot V; Canini L; Holzer B; Morgan S; ; Woolhouse MEJ; Tchilian E; Brookes SM; Brown IH; Charleston B; Gilbert S
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33268518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
    Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.
    Souza CK; Rajão DS; Loving CL; Gauger PC; Pérez DR; Vincent AL
    Clin Vaccine Immunol; 2016 Jun; 23(6):470-482. PubMed ID: 27030585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
    Hewitt JS; Karuppannan AK; Tan S; Gauger P; Halbur PG; Gerber PF; De Groot AS; Moise L; Opriessnig T
    Vaccine; 2019 Jul; 37(31):4302-4309. PubMed ID: 31248687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.
    Braucher DR; Henningson JN; Loving CL; Vincent AL; Kim E; Steitz J; Gambotto AA; Kehrli ME
    Clin Vaccine Immunol; 2012 Nov; 19(11):1722-9. PubMed ID: 22933397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.
    Loving CL; Lager KM; Vincent AL; Brockmeier SL; Gauger PC; Anderson TK; Kitikoon P; Perez DR; Kehrli ME
    J Virol; 2013 Sep; 87(17):9895-903. PubMed ID: 23824815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza A virus shedding reduction observed at 12 weeks post-vaccination when newborn pigs are administered live-attenuated influenza virus vaccine.
    Kaiser TJ; Smiley RA; Fergen B; Eichmeyer M; Genzow M
    Influenza Other Respir Viruses; 2019 May; 13(3):274-278. PubMed ID: 30843324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.
    Loving CL; Vincent AL; Pena L; Perez DR
    Vaccine; 2012 Aug; 30(40):5830-8. PubMed ID: 22835742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
    Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
    Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs.
    Rajão DS; Loving CL; Gauger PC; Kitikoon P; Vincent AL
    Vaccine; 2014 Sep; 32(40):5170-6. PubMed ID: 25077416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
    Kaplan BS; Souza CK; Gauger PC; Stauft CB; Robert Coleman J; Mueller S; Vincent AL
    Vaccine; 2018 Feb; 36(8):1101-1107. PubMed ID: 29366707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyanhydride nanovaccine against swine influenza virus in pigs.
    Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
    Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.
    Kitikoon P; Knetter SM; Mogler MA; Morgan CL; Hoehn A; Puttamreddy S; Strait EL; Segers RPAM
    Vaccine; 2023 Nov; 41(47):6941-6951. PubMed ID: 37884412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental transmission of avian-like swine H1N1 influenza virus between immunologically naïve and vaccinated pigs.
    Lloyd LE; Jonczyk M; Jervis CM; Flack DJ; Lyall J; Foote A; Mumford JA; Brown IH; Wood JL; Elton DM
    Influenza Other Respir Viruses; 2011 Sep; 5(5):357-64. PubMed ID: 21668691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus.
    Klingbeil K; Lange E; Teifke JP; Mettenleiter TC; Fuchs W
    J Gen Virol; 2014 Apr; 95(Pt 4):948-959. PubMed ID: 24431235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model.
    Lowen AC; Steel J; Mubareka S; Carnero E; García-Sastre A; Palese P
    J Virol; 2009 Apr; 83(7):2803-18. PubMed ID: 19153237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.